Home – News


ReviveMed Announces AI-driven Metabolomics Study with Bristol Myers Squibb

ReviveMed CEO selected as a 35 under 35 innovator by the MIT Technology review

ReviveMed Receives Frost & Sullivan AI-Driven Next-Generation Metabolomics Technology Innovation Award

ReviveMed CEO Dr. Pirhaji to present at TED2019, joining the newest class of 20 global visionaries.

ReviveMed – Most Innovative Company of the Year | 2018 Stevie Awards

ReviveMed received a 2nd LabCentral Golden Ticket Award from Bristol-Meyers Squibb

MIT Spinout, ReviveMed, Raises $1.5M to Advance its AI-Driven Metabolomic Platform for Drug Discovery

ReviveMed turns drug discovery into a big data problem and raises $1.5M to solve it

ReviveMed is the BioTech Winner of Extreme Tech Challenge 2018

ReviveMed received the Novartis & LabCentral Golden Ticket Award, sponsoring our lab space

ReviveMed was selected as a top 26 winners of MassChallenge Boston 2017

ReviveMed was selected as one of the 10 finalists for Google’s Cloud machine learning competition

ReviveMed is selected as a MassChallenge Boston’s 2017 finalist

ReviveMed team won $10K Booz Allen Hamilton analytics prize of MIT $100K competition, awarded to the most innovative analytic solution in businesses.

ReviveMed presents AI-Driven Drug Discovery @ MIT Intelligence Quest Launch

ReviveMed debuts at MassCONNECT showcase

ReviveMed CEO, Dr. Pirhaji, talked about ReviveMed’s origin story at MIT News